Haemonetics (HAE) Gross Profit (2016 - 2025)
Historic Gross Profit for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $202.4 million.
- Haemonetics' Gross Profit rose 456.68% to $202.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $782.4 million, marking a year-over-year increase of 691.57%. This contributed to the annual value of $749.0 million for FY2025, which is 830.17% up from last year.
- Per Haemonetics' latest filing, its Gross Profit stood at $202.4 million for Q4 2025, which was up 456.68% from $194.7 million recorded in Q3 2025.
- Over the past 5 years, Haemonetics' Gross Profit peaked at $202.4 million during Q4 2025, and registered a low of $81.8 million during Q2 2021.
- For the 5-year period, Haemonetics' Gross Profit averaged around $161.6 million, with its median value being $168.9 million (2023).
- Per our database at Business Quant, Haemonetics' Gross Profit tumbled by 2795.95% in 2021 and then soared by 6662.51% in 2022.
- Quarter analysis of 5 years shows Haemonetics' Gross Profit stood at $122.5 million in 2021, then rose by 29.51% to $158.7 million in 2022, then increased by 12.07% to $177.9 million in 2023, then increased by 8.82% to $193.5 million in 2024, then increased by 4.57% to $202.4 million in 2025.
- Its Gross Profit stands at $202.4 million for Q4 2025, versus $194.7 million for Q3 2025 and $192.2 million for Q2 2025.